Comparative Study of Three Different Formulations of Omega-3 (EPA+DHA)

Status Completed

Clinical Trial Summary

This pilot study aims at comparing the bioavailability of three different formulations of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The three formulations are ethyl ester (EE), triglyceride (TG) and monoglyceride (MAG). Thirty six (36) subjects will be divided in three groups of twelve subjects each equally divided in two study sites. Each group will be taking one of the three different formulations of EPA+DHA at a daily dose of 1.5g for a period of 12 weeks. Bioavailability will be measured through omega-3 index (total content of EPA + DHA in red blood cell membranes) at baseline and every four weeks during treatment.

Clinical Trial Description

This pilot study aims at comparing the bioavailability of three different formulations of a combination of omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a standardized proportion of 460:200. The three formulations are ethyl ester (EE), triglyceride (TG) and monoglyceride (MAG) versions of these fatty acids. The formulations are prepared in a way to be similar in proportion of EPA/DHA, in dose and in appearance. Thirty six (36) subjects will be divided in three groups of twelve subjects each, equally divided in two study sites. The study will be randomized and double blinded. Each group will be taking one of the three different formulations of EPA+DHA at a daily dose of 1.5g for a period of 12 weeks. Bioavailability will be measured through omega-3 index (total content of EPA + DHA in red blood cell membranes) at baseline and every four weeks during treatment. After recruitment, subjects will be seen in clinic every four weeks for a total of four (4) study visits during which a blood sample will be taken for analysis of the omega-3 index, the investigational product will be returned and dispensed and finally, adverse events will be noted and followed. Treatment will be self-administered by subjects at home. They will be asked to keep a journal of adverse events, concomitant medication and to note every missed dose as well as significant changes in life habits (smoking, alcohol, sports, food diet and natural health products intake). ;

Study Design

Related Conditions & MeSH terms

Healthy Adults

Clinical Trial Details

NCT number	NCT04159532
Study type	Interventional
Source	SCF Pharma
Contact
Status	Completed
Phase	Phase 4
Start date	December 18, 2019
Completion date	February 25, 2021

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04677920` - The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology	N/A
Active, not recruiting	`NCT03312920` - Investigating Memory Retrieval Improvement in Healthy Subjects	N/A
Completed	`NCT03309072` - Investigating Accelerated Learning and Memory in Healthy Subjects Using a Face Name Memory Task	N/A
Completed	`NCT03289832` - Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin	N/A
Enrolling by invitation	`NCT06133530` - Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica	N/A
Completed	`NCT05141903` - Dietary Supplement With and Without a Probiotic and/or Antibiotic
Completed	`NCT01689259` - Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults	Phase 1
Completed	`NCT01187875` - Resistant Starch and Satiety	Phase 0
Completed	`NCT03312699` - Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort	Phase 1
Completed	`NCT03319134` - Investigating the Neural Correlates in Memory Retrieval After HD-tDCS	N/A
Recruiting	`NCT04104360` - Galacto-oligosaccharides and Intestinal Activity	N/A
Completed	`NCT03228693` - Gene Expression and Biomarker Profiling of Keloid Skin	N/A
Completed	`NCT04206293` - A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers	N/A
Completed	`NCT04146532` - Aspirin Effects on Emotional Reactions	Early Phase 1
Recruiting	`NCT06011018` - Comparison of Effects of Mirror Therapy Combined With Neuromuscular Electrical Stimulation or Binaural Beats Stimulation on Cortical Excitability, Heart Rate Variability and Lower Limb Motor Function in Patients With Stroke	N/A
Completed	`NCT05093205` - STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS	Phase 1
Completed	`NCT04596709` - Investigation of Blood Glucose and Insulin Response After Intake of Vitalose	N/A
Completed	`NCT04272450` - Respiratory Muscle Strength in Different Age Groups
Completed	`NCT02044679` - Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions	N/A
Completed	`NCT01402973` - Pilot Study of a Dietary Intervention Based Upon Advanced Glycation End Products	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.